Transaction #3552 · Form 4 · 0001493152-25-020322
Anixa Biosciences Inc · Exercise / conversion · Common Stock
Anixa Biosciences Inc · Transacted October 30, 2025 · Filed October 31, 2025
What does this filing report?
An SEC Form 4 filing for Anixa Biosciences Inc records an exercise / conversion involving Common Stock on October 30, 2025. The reported quantity was 200,000. The filing date is October 31, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Anixa Biosciences Inc
- Company CIK
- 0000715446
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 200,000
- Reported price
- 2.92
- Reference value
- 584,000
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 779,925
- Ownership description
- Not reported
- SEC acceptance time
- Oct 31, 2025, 9:13 AM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- KUMAR AMIT ↗
Chief Executive Officer
CIK 0001191905
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The reporting person exercised the stock options at this time due to their upcoming expiration on February 18, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options.
- F2
- Right-To-Buy, pursuant to a stock option grant dated February 18, 2016.
- F3
- The option vested in 36 consecutive monthly installments beginning on March 31, 2016.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.